280 related articles for article (PubMed ID: 22533568)
21. Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches.
Liu DQ; Hop CE
J Pharm Biomed Anal; 2005 Feb; 37(1):1-18. PubMed ID: 15664738
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites.
Ma S; Zhu M
Chem Biol Interact; 2009 Apr; 179(1):25-37. PubMed ID: 18848531
[TBL] [Abstract][Full Text] [Related]
23. Use of a five-channel multiplexed electrospray quadrupole time-of-flight hybrid mass spectrometer for metabolite identification.
Leclercq L; Delatour C; Hoes I; Brunelle F; Labrique X; Castro-Perez J
Rapid Commun Mass Spectrom; 2005; 19(12):1611-8. PubMed ID: 15915450
[TBL] [Abstract][Full Text] [Related]
24. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for drug development.
Hsieh Y
Curr Drug Discov Technol; 2010 Sep; 7(3):223-31. PubMed ID: 20843291
[TBL] [Abstract][Full Text] [Related]
25. Herbal medicine analysis by liquid chromatography/time-of-flight mass spectrometry.
Zhou JL; Qi LW; Li P
J Chromatogr A; 2009 Oct; 1216(44):7582-94. PubMed ID: 19501368
[TBL] [Abstract][Full Text] [Related]
26. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies.
Plumb RS; Potts WB; Rainville PD; Alden PG; Shave DH; Baynham G; Mazzeo JR
Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2139-52. PubMed ID: 18543375
[TBL] [Abstract][Full Text] [Related]
27. Two-injection workflow for a liquid chromatography/LTQ-Orbitrap system to complete in vivo biotransformation characterization: demonstration with buspirone metabolite identification.
Li AC; Ding J; Jiang X; Denissen J
Rapid Commun Mass Spectrom; 2009 Sep; 23(18):3003-12. PubMed ID: 19681099
[TBL] [Abstract][Full Text] [Related]
28. Recent development in liquid chromatography/mass spectrometry and emerging technologies for metabolite identification.
Liang Y; Wang G; Xie L; Sheng L
Curr Drug Metab; 2011 May; 12(4):329-44. PubMed ID: 21395529
[TBL] [Abstract][Full Text] [Related]
29. Quantitation of parent drug and its unstable metabolites by in situ coulometric oxidation and liquid chromatography-tandem mass spectrometry.
Tong W; Chowdhury SK; Su AD; Alton KB
Anal Chem; 2010 Dec; 82(24):10251-7. PubMed ID: 21105697
[TBL] [Abstract][Full Text] [Related]
30. The development and assessment of high-throughput mass spectrometry-based methods for the quantification of a nanoparticle drug delivery agent in cellular lysate.
Buse J; Purves RW; Verrall RE; Badea I; Zhang H; Mulligan CC; Peru KM; Bailey J; Headley JV; El-Aneed A
J Mass Spectrom; 2014 Nov; 49(11):1171-80. PubMed ID: 25395133
[TBL] [Abstract][Full Text] [Related]
31. Enhanced metabolite identification with MS(E) and a semi-automated software for structural elucidation.
Bonn B; Leandersson C; Fontaine F; Zamora I
Rapid Commun Mass Spectrom; 2010 Nov; 24(21):3127-38. PubMed ID: 20941759
[TBL] [Abstract][Full Text] [Related]
32. LC-MS/TOF and UHPLC-MS/MS study of in vivo fate of rifamycin isonicotinyl hydrazone formed on oral co-administration of rifampicin and isoniazid.
Prasad B; Singh S
J Pharm Biomed Anal; 2010 Jul; 52(3):377-83. PubMed ID: 19692195
[TBL] [Abstract][Full Text] [Related]
33. The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet?
Nassar AE; Talaat RE; Kamel AM
Curr Opin Drug Discov Devel; 2006 Jan; 9(1):61-74. PubMed ID: 16445118
[TBL] [Abstract][Full Text] [Related]
34. Minimizing matrix effects while preserving throughput in LC-MS/MS bioanalysis.
Ye Z; Tsao H; Gao H; Brummel CL
Bioanalysis; 2011 Jul; 3(14):1587-601. PubMed ID: 21756092
[TBL] [Abstract][Full Text] [Related]
35. Comparative study of an estradiol enzyme-linked immunosorbent assay kit, liquid chromatography-tandem mass spectrometry, and ultra performance liquid chromatography-quadrupole time of flight mass spectrometry for part-per-trillion analysis of estrogens in water samples.
Farré M; Kuster M; Brix R; Rubio F; López de Alda MJ; Barceló D
J Chromatogr A; 2007 Aug; 1160(1-2):166-75. PubMed ID: 17540393
[TBL] [Abstract][Full Text] [Related]
36. 10 years of MS instrumental developments--impact on LC-MS/MS in clinical chemistry.
Himmelsbach M
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():3-17. PubMed ID: 22177236
[TBL] [Abstract][Full Text] [Related]
37. Comparison of unit resolution SRM and TOF-MS at 12,000 mass resolution for quantitative bioanalysis of 11 steroids from human plasma.
Rousu T; Tolonen A
Bioanalysis; 2012 Mar; 4(5):555-63. PubMed ID: 22409553
[TBL] [Abstract][Full Text] [Related]
38. In vivo metabolite detection and identification in drug discovery via LC-MS/MS with data-dependent scanning and postacquisition data mining.
Triolo A; Altamura M; Dimoulas T; Guidi A; Lecci A; Tramontana M
J Mass Spectrom; 2005 Dec; 40(12):1572-82. PubMed ID: 16320289
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments.
Borkar RM; Raju B; Srinivas R; Patel P; Shetty SK
Biomed Chromatogr; 2012 Jun; 26(6):720-36. PubMed ID: 21989963
[TBL] [Abstract][Full Text] [Related]
40. [Improvement of a multi-target screening analysis for drugs using a QTRAP liquid chromatography/tandem mass spectrometry system].
Miyagi H; Kajiwara M; Onishi H; Yamaguchi Y; Watanabe T
Rinsho Byori; 2007 Apr; 55(4):309-18. PubMed ID: 17511260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
